Bold, a Los Angeles-based company offering a healthy aging platform for older adults, closed a $17 million Series A funding round. The startup seeks to improve the health of Medicare Advantage beneficiaries through personalized exercise programs designed to prevent falls, decrease musculoskeletal pain and boost physical activity levels.

Integral raked in $6.9 million in seed funding in this week. The San Francisco-based startup is developing technology that seeks to speed up the process of exchanging sensitive health data while still maintaining robust privacy protection.

Genesis Therapeutics recently joined the growing list of AI-powered drug discovery startups receiving venture funding this year. The company closed a $200 million Series B financing round, taking its total funding to date to more than $280 million.

Viome Life Sciences’ Series C funding round included participation from Khosla Ventures, Bold Capital and WRG Ventures. In total, Viome has raised $175 million.

UpLift’s Series A funding round was led by Ballast Point Ventures and included participation from Kapor Capital, Front Porch Ventures and B Capital. In total, UpLift has raised more than $22 million.

PM Pediatric Care’s funding round was led by Scopia Capital and included participation from Jefferson River Capital. In total, the company has raised more than $140 million, said Steven Katz, co-founder and co-CEO of PM Pediatric Care.

Providence spinout DexCare recently closed a $75 million Series C funding round, bringing its total funding to date to $146 million. The startup gives health systems a platform that helps them coordinate and manage digital care services so they can better address the modern healthcare consumer’s demands for convenience and immediacy.

Strive Health’s $166 million funding round was led by NEA and included participation from CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, Ascension Ventures and Redpoint. In total, the company has raised more than $400 million.

Carrum Health’s $45 million funding round was led by OMERS Growth Equity and included participation from Revelation Partners, Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. It brings the company’s total financing to about $96 million.

Scene Health’s $17.7 million Series B funding round was led by ABS Capital Partners and includes participation from Claritas Health Ventures, PTX Capital, Kapor Capital and Healthworx, the investment arm of CareFirst BlueCross BlueShield. Since Scene Health was founded in 2014, it has raised more than $25 million total.

Last year’s digital health investment trends have left some startups feeling uneasy about their ability to raise capital in the new funding environment. Venture capitalists think companies that have a demonstrable return on investment and serve multiple stakeholders will probably have the easiest time securing capital, while point solutions and startups in crowded markets will face a tougher environment.

The funding round was led by Optum Ventures. Other investors include Adams Street Partners, Blue Shield of California and Humana. DispatchHealth will use the money to expand its capabilities in current markets, its CEO said.

NexHealth raised $125 million in a Series C funding round that was led by Buckley Ventures, the patient experience platform announced Thursday. The latest investment brings the company’s valuation to $1 billion.

The company — which has raised $16 million in total since its inception in 2019 — will use the new funds to enhance its health plan recommendation technology and expand its local Medicare agent network in Arizona and Texas.

Insightin Health aims to help payers retain and engage their members via its proprietary platform. The funding round was co-led by the Blue Venture Fund, a collaboration between Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association and Sandbox.